These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 31772147)

  • 21. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
    Tsutani Y; Suzuki K; Koike T; Wakabayashi M; Mizutani T; Aokage K; Saji H; Nakagawa K; Zenke Y; Takamochi K; Ito H; Aoki T; Okami J; Yoshioka H; Okada M; Watanabe SI;
    Ann Thorac Surg; 2019 Nov; 108(5):1484-1490. PubMed ID: 31336067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Can Quantitative Volumetric Analysis Predict Tumor Recurrence in the Patients with Mucinous Adenocarcinoma of the Lung After Surgical Resection?
    Lim JK; Shin KM; Lee HJ; Lee H; Hahm MH; Lee J; Kim CH; Cha SI; Jeong JY; Park TI
    Acad Radiol; 2019 May; 26(5):e21-e31. PubMed ID: 30064921
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognosis for Pneumonic-Type Invasive Mucinous Adenocarcinoma in a Single Lobe on CT: Is It Reasonable to Designate It as Clinical T3?
    Kim W; Lee SM; Lee JB; Seo JB; Kim HK; Kim J; Lee HY
    Korean J Radiol; 2022 Mar; 23(3):370-380. PubMed ID: 35213098
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solid predominant histologic subtype and early recurrence predict poor postrecurrence survival in patients with stage I lung adenocarcinoma.
    Luo J; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Huang Q; Wang Y; Zheng J; Chen H
    Oncotarget; 2017 Jan; 8(4):7050-7058. PubMed ID: 27732964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C-reactive protein-albumin ratio is an independent prognostic predictor of tumor recurrence in stage IIIA-N2 lung adenocarcinoma patients.
    Yamauchi Y; Safi S; Muley T; Warth A; Herth FJF; Dienemann H; Hoffmann H; Eichhorn ME
    Lung Cancer; 2017 Dec; 114():62-67. PubMed ID: 29173768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor Spread through Air Spaces Affects the Recurrence and Overall Survival in Patients with Lung Adenocarcinoma >2 to 3 cm.
    Dai C; Xie H; Su H; She Y; Zhu E; Fan Z; Zhou F; Ren Y; Xie D; Zheng H; Kadeer X; Chen D; Zhang L; Jiang G; Wu C; Chen C
    J Thorac Oncol; 2017 Jul; 12(7):1052-1060. PubMed ID: 28389373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Surgically resected solitary cavitary lung adenocarcinoma: association between clinical, pathologic, and radiologic findings and prognosis.
    Watanabe Y; Kusumoto M; Yoshida A; Suzuki K; Asamura H; Tsuta K
    Ann Thorac Surg; 2015 Mar; 99(3):968-74. PubMed ID: 25620598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic impact of preoperative monocyte counts in patients with resected lung adenocarcinoma.
    Kumagai S; Marumo S; Shoji T; Sakuramoto M; Hirai T; Nishimura T; Arima N; Fukui M; Huang CL
    Lung Cancer; 2014 Sep; 85(3):457-64. PubMed ID: 25043641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis of epidermal growth factor receptor-mutated stage I lung adenocarcinoma with radiologically solid features.
    Hattori A; Matsunaga T; Fukui M; Takamochi K; Suzuki K
    Eur J Cardiothorac Surg; 2022 Mar; 61(4):769-777. PubMed ID: 34791156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of adjuvant chemotherapy for lung adenocarcinoma patients with positive pleural lavage cytology findings.
    Ogawa H; Uchino K; Tanaka Y; Shimizu N; Okuda Y; Tane K; Tauchi S; Nishio W; Maniwa Y; Yoshimura M
    Interact Cardiovasc Thorac Surg; 2015 Jul; 21(1):34-9. PubMed ID: 25911680
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A combination of preoperative CT findings and postoperative serum CEA levels improves recurrence prediction for stage I lung adenocarcinoma.
    Yamazaki M; Ishikawa H; Kunii R; Tasaki A; Sato S; Ikeda Y; Yoshimura N; Hashimoto T; Tsuchida M; Aoyama H
    Eur J Radiol; 2015 Jan; 84(1):178-184. PubMed ID: 25455413
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic and predictive value of the novel classification of lung adenocarcinoma in patients with stage IB.
    Luo J; Huang Q; Wang R; Han B; Zhang J; Zhao H; Fang W; Luo Q; Yang J; Yang Y; Zhu L; Chen T; Cheng X; Wang Y; Zheng J; Wu H; Xia W; Chen H
    J Cancer Res Clin Oncol; 2016 Sep; 142(9):2031-40. PubMed ID: 27379889
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
    Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
    J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Frequency and Prognostic Impact of Pathological Microscopic Vascular Invasion According to Tumor Size in Non-Small Cell Lung Cancer.
    Shimada Y; Saji H; Kato Y; Kudo Y; Maeda J; Yoshida K; Hagiwara M; Matsubayashi J; Kakihana M; Kajiwara N; Ohira T; Ikeda N
    Chest; 2016 Mar; 149(3):775-85. PubMed ID: 26379115
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of number of metastatic lymph nodes and metastatic lymph node ratio on the prognosis in patients with adenocarcinoma of the esophagogastric junction after curative resection].
    Zhang H; Chen C; Yue J; Ma M; Ma Z; Yu Z
    Zhonghua Zhong Liu Za Zhi; 2014 Feb; 36(2):141-6. PubMed ID: 24796465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incorporation of the lepidic component as an additional pathological T descriptor for non-small cell lung cancer: Data from 3335 cases of lung adenocarcinoma.
    Huang S; Zhao M; Li S; Chen T; Zhong Y; Deng J; Xu L; Wu J; Xie X; Wu C; Hou L; She Y; Zheng H; Chen C
    Lung Cancer; 2024 Mar; 189():107472. PubMed ID: 38320371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Elevated MACC1 expression predicts poor prognosis in small invasive lung adenocarcinoma.
    Guo T; Zhao S; Li Z; Li F; Li J; Gu C
    Cancer Biomark; 2018; 22(2):301-310. PubMed ID: 29630522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. KRAS Mutation Is a Significant Prognostic Factor in Early-stage Lung Adenocarcinoma.
    Kadota K; Sima CS; Arcila ME; Hedvat C; Kris MG; Jones DR; Adusumilli PS; Travis WD
    Am J Surg Pathol; 2016 Dec; 40(12):1579-1590. PubMed ID: 27740967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk Factors of Recurrence in Patients With Clinical Stage IA Adenocarcinoma Presented as Ground-Glass Nodule.
    Su H; Dai C; Xie H; Ren Y; She Y; Kadeer X; Xie D; Zheng H; Jiang G; Chen C
    Clin Lung Cancer; 2018 Sep; 19(5):e609-e617. PubMed ID: 29803575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New IASLC/ATS/ERS classification and invasive tumor size are predictive of disease recurrence in stage I lung adenocarcinoma.
    Yanagawa N; Shiono S; Abiko M; Ogata SY; Sato T; Tamura G
    J Thorac Oncol; 2013 May; 8(5):612-8. PubMed ID: 23584293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.